vizient

MARCH 7, 2024

A Vizient white paper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancers.

98

98

Pharmaceutical Commerce

MARCH 25, 2024

The organizations conducted an in-depth study of the program over the course of two years, publishing a white paper on the findings.

52

52

PharmaTech

NOVEMBER 6, 2023

In this white paper, Pfizer CentreOne discusses how a small or medium sized biotech or pharma company can benefit from the experience and assistance provided by a CDMO.

52

52

PharmaTech

NOVEMBER 19, 2023

This white paper from Jubilant HollisterStier discusses the range of factors to consider when outsourcing manufacturing for aseptically filled and terminally sterilized products. Vetting a CMO for sterile injectable fill finish means more than capacity and equipment.

52

52

PharmaTech

OCTOBER 10, 2023

This white paper discusses the role of project management at Jubilant HollisterStier in creating and executing transfer plans and the innovative solutions developed for the transfer of five COVID-19 vaccine and therapeutic fill finish manufacturing projects. Central to a successful technology transfer is effective project management.

Vaccines 52

Vaccines 52

Drug Channels

SEPTEMBER 22, 2023

To learn about CoverMyMeds’ medication affordability solutions that engage patients, download the CoverMyMeds white paper: Overcoming Affordability Challenges with Patient-Centered Solutions. Read on for Kristina’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

90

90

pharmaphorum

SEPTEMBER 18, 2020

The Transformational Value: Preparing for a Decade of Radical Change white paper from the Adelphi Group sets out the key tenets of the concept and the opportunity for pharma to take a big picture view of ‘transformational value’ and how to respond to it. The post Preparing for a decade of radical change in pharma appeared first on.

96

96

Pharma and Life Sciences Blog

DECEMBER 15, 2023

This white paper — Conquering Costs: How High-Growth Enterprise CFOs Can Gain Real Cost Control With Real-Time Data — explores the role visibility and access to end-to-end data have in controlling costs. What do they need so that they can make informed decisions when speed is of the essence?

52

52

PharmaTech

DECEMBER 19, 2023

Our white paper compares this with USP Chapters and. The European Pharmacopoeia's new Chapter 2.1.7 on analytical balances was published on July 1, 2021, and became mandatory for pharma companies in Europe from January 1, 2022. It outlines calibration and performance standards for balances.

40

40

Drug Channels

SEPTEMBER 22, 2023

To learn about CoverMyMeds’ medication affordability solutions that engage patients, download the CoverMyMeds white paper: Overcoming Affordability Challenges with Patient-Centered Solutions. Read on for Kristina’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

74

74

pharmaphorum

NOVEMBER 20, 2020

Havas Lynx Group’s 2020 white paper provides a blueprint for pharma brands to inject meaning into their media. The latter is the subject of our 2020 white paper, Media Means Business. Download the Media Means Business white paper today at [link]. What do we mean by ‘media’? About the author.

98

98

Pharma and Life Sciences Blog

APRIL 18, 2024

In our latest white paper — Next-Gen Procurement: Transforming Processes With the Power of Generative AI — experts reveal how applying generative AI strategically within procurement process paves the way for groundbreaking improvements.

52

52

pharmaphorum

AUGUST 28, 2020

In The Medscape Professional Networks’ latest white paper, Healthcare’s New Normal: COVID Speeds Shift to Digital Communications , key opinion leaders and industry experts agree that in the post-pandemic world, even as lockdowns are lifted and restrictions relaxed, the emerging trends for an increase in digital communications will stay.

Communication 77

Communication 77

PharmaTech

OCTOBER 10, 2023

This white paper from Jubilant HollisterStier discusses the range of factors to consider when outsourcing manufacturing for aseptically filled and terminally sterilized products. Vetting a CMO for sterile injectable fill finish means more than capacity and equipment.

40

40

Pharma and Life Sciences Blog

AUGUST 25, 2023

Our new white paper, Procurement Software Today: What Buyers and End Users Really Want, details the most important factors to consider when choosing the procurement platform to deploy across your enterprise. With so many vendors and solutions out there, you need a way to separate the best from the rest.

52

52

Pharma and Life Sciences Blog

AUGUST 21, 2023

Our new white paper, How Financial Services Companies Can Excel in ESG Goals, is an actionable guide for business and supply chain leaders looking to take the opportunity to impact an ecosystem that is ripe for meaningful transformation.

52

52

Pharmaceutical Commerce

NOVEMBER 21, 2023

Discover which solution is right for you in our white paper. Deciding which temperature monitoring solution will work best for your operation depends upon the product, its value, delivery method and stage in the supply chain.

40

40

pharmaphorum

NOVEMBER 9, 2021

A new white paper from 60 Seconds, Genuine Transformation: Preparing for Pharma’s New Sales Coaching Reality , looks at the recent evolution of the pharma sales function and discusses how training and coaching changed during the pandemic and how to prepare for what is coming next. This white paper explains how to adjust to it.

Communication 77

Communication 77

Pharmaceutical Commerce

NOVEMBER 21, 2023

This white paper dives into vaccine distribution plans and what vaccine manufacturers, distributors and administrators can take away from this monumental time in both the industry and history. Delivering COVID-19 vaccines to 7.8 billion people was a daunting challenge that stretched supply chains past their limits.

Vaccines 40

Vaccines 40

PharmaTech

APRIL 11, 2023

This white paper details the challenges to optimizing the emerging supply chain, from manufacture through clinical trials to market, and how they may be overcome.

40

40

Pharma and Life Sciences Blog

MARCH 22, 2024

This white paper — How Pharma Companies Can Optimize Clinical Trial Operations and Unlock Value — explores how focusing on people, process and technology can help organizations expedite clinical trials and control costs while still juggling several stakeholder groups to ensure a successful clinical trial launch.

52

52

pharmaphorum

MAY 4, 2021

The key trends for these sectors are identified and analysed in a new white paper from Healthware Group that offers guidance on how companies can best adjust to the new digital scenario. In the white paper, expert contributors share a detailed picture of the digital trends with the greatest potential to impact the near future.

82

82

PharmaTech

MAY 29, 2023

The white paper provides information on important approaches to making solids production more flexible and how agile systems can help. Learn how flexible systems bring the decisive advantage to simply switch between the technologies of which you can benefit already in the development phase of solids.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing 52

PharmExec

AUGUST 24, 2022

In this paper, learn about a variety of genetic analysis methods and how they’re valuable in ensuring that ex vivo human cells used for cell?based Download the white paper and read more about the importance of quality control (QC) for isolated human cells and tissues.

52

52

PharmaTech

JULY 20, 2022

In this white paper, we explore the processes, operations, and customer-focused approach of Emergent CDMO's integrated internal teams, providing efficient organization alongside smooth and timely technology transfer and scale-up, from R&D to GMP manufacturing.

40

40

PharmaTech

OCTOBER 11, 2023

Learn how to avoid these roadblocks by reading this white paper from Societal™ CDMO. Unfortunately, as time passes, there is an increased risk of CMC issues becoming more complicated, time-consuming, and expensive to fix.

40

40

PharmaTech

DECEMBER 4, 2022

This white paper will cover the various elements that are critical to consider when selecting a PGM heterogeneous catalyst for your process. To ensure optimal processes, catalyst design is of paramount importance.

40

40

PharmaTech

AUGUST 7, 2022

This white paper highlights Pharma’s data integrity challenge and its impact on manufacturing, and proposes solutions for Pharma’s successful digital transformation journey.

40

40

PharmaTech

AUGUST 9, 2022

This white paper introduces a method for reducing harvesting time of yeast, bacteria, or cell cultures by up to 32% using the Eppendorf Centrifuge CR22N or CR30NX with unique triangular 1.5 L bottles.

40

40

Pharma and Life Sciences Blog

FEBRUARY 23, 2024

This white paper — 2024 GEP Procurement & Supply Chain Tech Trends Report — explores the biggest technological trends in procurement and supply chain, from generative AI and the advancement of low-code development tools to the data management and analytics applications that unlock agility, cost efficiency and informed decision-making.

52

52

PharmaTech

SEPTEMBER 12, 2022

Read how continuous monitoring supports validation and compliance in our white paper. A comprehensive cleanroom monitoring strategy combines data acquisition, analysis, and reporting to support compliance efforts and protect valuable scientific work.

40

40

PharmaTech

DECEMBER 14, 2022

The objective of this white paper is to discuss the suitability of this versatile excipient in parenteral drug products and provide an updated summary of regulated parenteral drug delivery products in which DMSO is incorporated.

40

40

PharmaTech

MAY 29, 2023

The white paper provides information on important approaches to making solids production more flexible and how agile systems can help. Learn how flexible systems bring the decisive advantage to simply switch between the technologies of which you can benefit already in the development phase of solids.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing 40

PharmaTech

SEPTEMBER 12, 2022

This white paper states critical parameters in a lab or life science facility that should be monitored by a 24/7 real-time data acquisition system. When life science facilities are forced to shut down, or operate with fewer staff, it exposes a severe lack of capabilities to monitor critical assets and environments.

40

40

Pharma and Life Sciences Blog

NOVEMBER 3, 2023

GEP partnered with Procurement Leaders on this paper — Supplier Partnerships in the Digital-First Economy: How To Create Value and Drive Innovation — which outlines how technology enables procurement to act quickly, decisively and tactically.

52

52

PharmaTech

OCTOBER 22, 2023

Unlock the content to read the full white paper. Digital and decentralized technologies have the potential to revolutionize the landscape of oncology trials, offering solutions that can alleviate many of the challenges faced.

40

40

PharmaTech

JULY 16, 2023

In this white paper, we explore the importance of purposefully aligning the overall drug development strategy with a partnering strategy. With hundreds of potential partners that drug owners can choose from to develop and manufacture small molecule APIs, choosing the best partner can be a challenging task.

Drug Development 40

Drug Development 40